Modeling Restoration of Gefitinib Efficacy by Co-Administration of MET Inhibitors in an EGFR Inhibitor-Resistant NSCLC Xenograft Model: A Tumor-in-Host DEB-Based ApproachCPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1396-1411. Tosca EM, Gauderat G, Fouliard S, Burbridge M, Chenel M, Magni P.JournalMIDDOncologyPharmacometricsPharmetheus Affiliates Chief Research OfficerMarylore ChenelSee bio
